
Jeff McClean says A.I. valuations have ballooned to the point where the value in many have been lost. He points attention to names beyond key A.I. players as financial opportunities. Jeff says many can be found in the broad small caps sector, arguing that the recent rate cut and other tentative cuts in 2025 heavily benefit Russell 2000 names. He adds that Novo Nordisk (NVO) will regain momentum with its Ozempic drug after the stock was "beaten down" over the last year. In the Mag 7, Jeff still expects more upside potential in Alphabet (GOOGL).
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7
Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch
Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore
Watch on DistroTV - https://www.distro.tv/live/schwab-network/
Follow us on X – https://twitter.com/schwabnetwork
Follow us on Facebook – https://www.facebook.com/schwabnetwork
Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/
About Schwab Network - https://schwabnetwork.com/about
More episodes from "Schwab Network"
Don't miss an episode of “Schwab Network” and subscribe to it in the GetPodcast app.